Table 2 Dose criteria of the PACE-C trial [34]

CTV

40

 ≥ 95%

(allowed minor variations: 90%-94.9%)

PTV

36.25

 ≥ 95%

(allowed minor variations: 90%-94.9%)

34.4

98%

Organs at risk

Rectum

36

 < 2 cm³

29

 < 20%

18.1

 < 50%

Bladder

37

 < 10 cm³

18.1

 < 40%

Bowel

18.1

 < 5 cm³

30

 < 1 cm³

Femoral heads

14.5

 < 5%

Penile bulb

29.5

 < 50%